Opposite effects of amiodarone and  -blocking agents on cardiac function under adrenergic stimulation.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D001572:Benzofurans / Q000494:pharmacology*; D001783:Blood Flow Velocity; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D004285:Dogs; D004357:Drug Synergism; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D005021:Ethylamines / Q000494:pharmacology; D005260:Female; D006321:Heart / Q000187:drug effects*; D006334:Heart Function Tests; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*; D013696:Temperature; D013814:Thermal Conductivity
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001565:Benzoates; D001572:Benzofurans; D005021:Ethylamines; D013565:Sympatholytics; D011433:Propranolol; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine